INVO Bioscience Ownership | Who Owns INVO Bioscience?
INVO Bioscience Ownership Summary
INVO Bioscience is owned by 0.84% institutional investors, and 99.16% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.38% of its assets in INVO Bioscience shares.
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2023 | 1 | -94.12% | 32,000 | -96.67% | - | 0.13% | - | -100.00% | 1 | -50.00% |
Jun 30, 2023 | 17 | -19.05% | 959,710 | -60.23% | 25 | 0.63% | 6 | -14.29% | 2 | -50.00% |
Mar 31, 2023 | 21 | - | 2,412,873 | 83.67% | 63 | 5.32% | 7 | -22.22% | 4 | 300.00% |
Dec 31, 2022 | 21 | 40.00% | 1,313,711 | -0.73% | 34 | 2.85% | 9 | 350.00% | 1 | -50.00% |
Sep 30, 2022 | 15 | -11.76% | 1,323,356 | -7.00% | 34 | 4.06% | 2 | -66.67% | 2 | -33.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Institutional Extnd Mkt Idx Tr | 54.06K | 1.38% | - |
Fidelity Extended Market Index | 22.78K | 0.58% | 3.25K |
Fidelity Series Total Market Index | 6.17K | 0.16% | - |
Fidelity Nasdaq Composite Index | 5.05K | 0.13% | - |
Fidelity Total Market Index | 1.20K | 0.03% | - |
State St US Extended Mkt Indx NL Cl C | 843.00 | 0.02% | - |
SSgA U.S. Extended Market Index Class I | 843.00 | 0.02% | - |
SSgA U.S. Total Market Index Strategy | 346.00 | 0.01% | 103.00 |
Northern Trust Extended Eq Market Idx | 341.00 | 0.01% | - |
NT Ext Equity Mkt Idx Fd - L | 341.00 | 0.01% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 01, 2022 | Shum Steve | Chief Executive Officer | Buy | $55.94K |
Jun 01, 2022 | Szot Matthew K | Buy | $13.75K | |
Jun 01, 2022 | Ryan Barbara | Buy | $10.00K | |
Jun 01, 2022 | DAVIS TRENT D | Buy | $10.62K | |
Jun 01, 2022 | Segal Jeffrey | Buy | $8.75K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2022 Q2 | 9 | - |
2022 Q1 | - | - |
2021 Q4 | 2 | - |
2021 Q2 | 14 | - |
2020 Q4 | - | - |
INVO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools